Scott Pomerantz, CEO & President
Scott has spent his career developing and scaling visionary technologies for global markets. His drive to bring innovative technology solutions to market brought him to the MC10 team in 2014 after a successful 7-year career with Broadcom, a global leader in semiconductors for wired and wireless communications, where he most recently served as the Senior Vice President and General Manager of Wireless Connectivity, Broadcom’s largest business. Prior to Broadcom, he co-founded Global Locate, a GPS company where he served as CEO, President and Chairman of the Board before it was sold to Broadcom in 2007. MC10’s rapid growth provides a unique opportunity to leverage Scott’s well-rounded background in leading both small and large companies. Scott holds an MBA from the William E. Simon Graduate School of Management and a Bachelor’s Degree from the University of Rochester. He is a member of the Board of Advisors at the Hajim School of Engineering at the University.
Alice Sansone, VP & General Counsel
Alice has spent her career counseling high-tech companies on complicated intellectual property issues, commercial negotiations, manufacturing and supply chain matters, merger and acquisition activity, and corporate growth and strategy. Prior to joining MC10 in 2013, she was the General Counsel of Kiva Systems, which pioneered disruptive robotic automation technology in the material handling industry and was acquired by Amazon for $775M in 2012. Prior to Kiva, Alice was counsel to Avid Technology, a publicly traded media company that delivers innovative digital non-linear editing technology to the film and television industry. Alice has also served as General Counsel to four emerging technology companies based in New Hampshire, and began her career in private practice at a major Boston law firm. Alice received a B.A. Phi Beta Kappa from Wellesley College, a J.D. from NYU School of Law, and studied Political Philosophy at the University of Oxford.
Benjamin Schlatka, VP of Corporate Development, Co-Founder
Ben’s passion for growing and leading science based businesses led him to co-found MC10 in 2008. His multidisciplinary expertise in both material science and electronics uniquely position him to lead MC10’s partnership activities and growth across its Medical, Consumer, and Government segments. Ben’s career has been spent scaling technology enabled businesses. Prior to MC10, Ben helped grow Nantero’s carbon nanotube electronics business (sold to Lockheed Martin Corporation) and led marketing and sales for a Volunteer Solutions.org (winner 1998 MIT 50K, sold to the United Way). He began his career as a corporate intraprenuer as one of the founding team members of IBM’s Networking Hardware microelectronics business – today greater than a billion dollars in sales. Ben has been an invited key note speaker at Fortune 100 companies on strategies for growing disruptive science driven innovations. Ben’s other passion is coaching individuals on building their careers in technology and serves as an executive coach at the Harvard Business School. Ben earned an MBA from the Harvard Business School and holds 2 issued patents with 11 pending.
Don Fuchs, VP of Strategy and Marketing
Don’s diverse background in electrical, structural and process engineering combined with his extensive experience in strategic marketing and business development propelled him to join the MC10 team in 2014. As co-founder of Global Locate, he built and managed the company’s marketing and business development teams until it was sold to Broadcom Corporation in 2007. He continued on at Broadcom as the Director of Business Development, working to build the company’s connectivity market share in the growing consumer wearables market. Don holds a B.S. in Mechanical Engineering from Fairleigh Dickinson University.
Jesus Pindado, VP of Engineering
Jesus joins the MC10 team from a successful career in technology business development and software & data product management. His most recent work involves the design and launch of Systemia, a quantitative asset management company built on programmatic trading strategies and statistical models. Prior to Systemia, he was VP and GM of the Retail Business Unit at Strands Labs, a data analytics company, where he led the development and commercialization of a SaaS behavioral targeting platform focused on online retail. Jesus held engineering and product management roles at Global Locate, mostly focusing on integrating GPS ASICs and software products into mobile phones before Broadcom Corporation acquired the company in 2007. He has also held systems engineering roles at Orbital Sciences Corporation developing software and testing avionics and telemetry systems for a NASA-funded drone program. Jesus holds a B.S. in Aerospace Engineering from the University of Michigan.
Roozbeh Ghaffari, VP of Technology & Co-Founder
Rooz’s inventions in the field of stretchable bio-electronics have laid the technology foundation for MC10 Inc. Rooz drives MC10’s technical vision in the areas of wearable consumer health and medical devices. Prior to co-founding MC10, Rooz helped launch Diagnostics For All, a nonprofit organization developing low cost health diagnostics using patterned-paper microfluidics. Rooz’s contributions have been recognized with the Helen Carr Peake Research Prize, the MIT 100K and Harvard Business Social Enterprise Awards, and the MIT Technology Review’s Top 35 Innovators Under 35. Rooz has published over 30 research papers and is inventor on over 30 patents applications and awards. Rooz obtained his Bachelor’s and Master’s degrees in Electrical Engineering from the Massachusetts Institute of Technology, and his PhD degree in Biomedical Engineering from the Harvard-MIT Division of Health Sciences and Technology.
Steven Tannenbaum, VP & CFO
Steve joins the MC10 team from a 25-year career successfully driving early stage companies to new levels of success through mergers, acquisitions, and IPOs. As the Executive Vice President and CFO of PreCision Dermatology, Inc., Steve successfully led and managed numerous debt and equity financings raising over $100 million as well as the sale of PreCision to Valeant Pharmaceuticals International (NYSE:VRX) in a transaction valued at approximately $0.5bn. Prior to PreCision Dermatology, Steve served as Executive VP & CFO of Collegium Pharmaceutical, Inc, where he completed 5 Preferred series of VC financings, as well as the spin-out of Precision Dermatology. Steve began his career as a Certified Public Accountant with PriceWaterhouseCoopers and holds a Bachelors of Science in Business Administration from Northeastern University.
Board of Directors
Carmichael Roberts, Chairman and Co-Founder
Carmichael Roberts brought the technology and team together to form MC10 in 2008, and has served as the company’s Chairman and Co-Founder ever since. Carmichael started his career as a technologist, subsequently moving into business “developing applications for his research interests,” and then moving on to entrepreneurship and venture capitalism, exploring ways to finance those businesses. He joined North Bridge Venture Partners in 2007, focusing primarily on building companies based predominately on innovative materials technologies. A serial entrepreneur, Carmichael founded and ran several companies prior to joining North Bridge, including Arsenal Medical and Nano-Terra. In 1999 he was named one of the world’s top 100 young entrepreneurs by MIT’s Technology Review. Prior to his entrepreneurial career, Carmichael worked in business development at GelTex Pharmaceuticals, which was acquired by Genzyme for $1.3 billion, and in new product and business development at Dow Chemical. Carmichael received his B.S. and Ph.D. in organic chemistry from Duke University and completed a National Science Foundation postdoctoral fellowship at Harvard University. Carmichael also received his M.B.A. from the MIT Sloan School of Management. He serves as an advisor for MIT’s Deshpande Center for Technological Innovation, Harvard’s Nanoscale Science and Engineering Center, and schools of Science and Engineering at Duke University.
John Rogers, Co-Founder
The technical founder of MC10 and father of MC10’s conformal electronics technology, John Rogers is passionate about doing cutting-edge research and seeing it applied in real products that have an impact on the world. As the Lee J. Flory-Founder Chair Professor of Engineering at the University of Illinois, Urbana- Champaign, with a primary appointment in Materials Science and Engineering, John leads one of the largest and most productive research groups on the planet, with more than 45 PhD and post-doc student working on different aspects of electronic materials. Prior to UIUC he was the former Director of Condensed Matter Physics Research at Bell Laboratories. John has published over 300 papers and holds nearly 80 patents, and serves actively on MC10’s Board of Directors and Technology Advisory Board. John’s honors include the Lemelson/MIT Prize (2011) and a MacArthur Fellowship (2009) among many others. John received a B.S. in Physics and B.A. in Chemistry from the University of Texas at Austin, an SM in Physics and Chemistry and Ph.D. in Physical Chemistry from MIT, and was a Junior Fellow of the Society of Fellows at Harvard.
Jiong Ma, Partner at Braemar Energy Ventures
Jiong has more than 14 years of research, operating and venture capital experience in the technology industry. Prior to joining Braemar, she was with the venture group at 3i, a global private equity firm. At 3i, Dr. Ma was responsible for investment in the information technology and cleantech sectors. Prior to 3i, Dr. Ma held several senior positions at Lucent Technologies and Bell Labs.. Dr. Ma received a Ph.D. in electrical engineering from the University of Colorado at Boulder, an M.S. in electrical engineering from the Worcester Polytechnic Institute in Massachusetts, and a B.S. in physics from Lanzhou University, China. She is a graduate of the Kauffman Fellows Program, has published or co-authored 15 technical papers, and holds one U.S. patent.
Paul Klingenstein, Managing Partner at Aberdare Ventures
Paul has been a venture capital investor focused on healthcare innovation and young companies for most of his professional career. Beginning at Warburg, Pincus in the early 1980s, he joined Accel Partners in 1986 and helped, through the next decade, to build a leading venture capital firm. After a brief period as an advisor to the Rockefeller Foundation, he formed Aberdare Ventures in 1999. During this time he has invested in more than 50 companies, the majority of which are now public or have been merged into public companies. Paul received an AB from Harvard and an MBA from Stanford.
Marc Singer, Managing Partner at Osage Partners
Marc joined Osage in 2008 as a fifteen year veteran in venture capital industry. Marc was previously a General Partner of BEV Capital, an early stage venture capital firm he co-founded in 1997. Over the last ten years Marc helped BEV raise and invest over $200M in over 40 companies and co-invested with over 100 other venture capital firms. Marc managed or co-managed eighteen of BEV’s investments, served as an active board member and/or Chairman for the majority of his investments, and successfully managed multiple companies from start-up through IPO or trade sale. Prior to co-founding BEV in 1997, Marc worked at Consumer Venture Partners, another venture capital firm which he joined in 1993. Marc earned his BS from The Wharton School of the University of Pennsylvania.